
Cheryl A. Grandinetti, PharmD
Articles by Cheryl A. Grandinetti, PharmD


Pneumonia and influenza together represent the seventh leading cause of death in the United States. Pharmacists can influence care by ensuring that appropriate therapy is initiated quickly and closely monitoring patients.

Tuberculosis remains a major global health concern?it is important for the pharmacist to focus on patient medication adherence to avoid drug resistance.

Pharmacists can improve care of patients with hepatitis B or C through recommendations, monitoring, and education.


Dr. Grandinetti is a senior clinical research pharmacist at the National Cancer Institute, National Institutes of Health, Rockville, Md. The views expressed are those of the author and not those of any government agency.

The views expressed are those of the author and not those of any government agency.
Latest Updated Articles
Inflammatory Bowel DiseaseMay 15th 2009
Treatment Goals for Drug-Resistant TuberculosisNovember 1st 2008
Helping Hepatitis Patients Manage Their DiseaseFebruary 1st 2008
Continuity of Care: Treating the Cataract PatientJanuary 1st 2008
PEP for HIV, Hepatitis B, and Hepatitis C May Reduce RiskAugust 1st 2007